-
SAR131675: A VEGFR-3 Inhibitor Workflow
2026-09-07
Build cleaner lymphangiogenesis and angiogenesis assays with SAR131675, a selective ATP-competitive probe that separates VEGFR-3 biology from broader kinase effects. This workflow connects receptor phosphorylation, endothelial survival, migration, and tumor-model readouts while clarifying how nicotine–kidney research can inform, but not validate, vascular experiments.
-
Praeruptorin A: Ferroptosis Research Workflows
2026-09-07
Praeruptorin A connects Fe²⁺-centered screening with practical studies of doxorubicin cardiotoxicity, inflammation, intestinal barrier injury, and tumor-cell invasion. This workflow-focused guide explains how to prepare, dose, validate, troubleshoot, and extend the compound without confusing preclinical evidence with clinical proof.
-
Dlin-MC3-DMA LNP Workflow for RNA Delivery
2026-09-05
Dlin-MC3-DMA combines potent endosomal escape with a practical formulation workflow for siRNA and mRNA research. This guide connects hepatic gene silencing benchmarks with machine-learning-guided microglia assays, while emphasizing formulation controls, assay design, and troubleshooting.
-
Remdesivir (GS-5734) in Emerging RNA Virus Research
2026-09-04
Remdesivir (GS-5734) provides a mechanistic benchmark for RNA-dependent RNA polymerase research. This article shows how to interpret its coronavirus and filovirus data alongside a Bourbon virus mouse study without conflating assay evidence with therapeutic proof.
-
Hydroxycinnamic Acids Block COPII–STING Trafficking
2026-09-04
This study identifies the Sec24 B-site of the COPII coat complex as a molecular target of cinnamic, caffeic, and ferulic acids, linking cargo sorting to cGAS–STING-driven inflammation. Structural, cellular, and diabetic-mouse data show that disrupting STING trafficking can reduce steatosis, improve metabolic parameters, and alleviate hepatic injury, although translation beyond preclinical models remains to be established.
-
Hexamethonium Bromide: Autonomic AChR Blockade
2026-09-03
Hexamethonium Bromide is a selective antagonist of neuronal-type nicotinic AChR at autonomic ganglia. Its ganglionic blockade provides an experimental way to test autonomic contributions to cardiovascular phenotypes, including sex-dependent angiotensin II hypertension, without equating blood-pressure reduction with a single molecular mechanism.
-
Caspase-3 Activity as a Translational Decision Signal
2026-09-03
Caspase-3 activity can convert a broad cell-death phenotype into a mechanistically interpretable signal. This thought-leadership guide connects the hyperthermia–cisplatin literature with practical assay design, positioning the Caspase-3 Fluorometric Assay Kit as a functional tool for apoptosis research, pathway validation, and translational decision-making.
-
Thapsigargin: SERCA Pump Inhibitor Guide
2026-09-02
Thapsigargin is a potent SERCA pump inhibitor used to perturb intracellular calcium homeostasis and trigger endoplasmic reticulum stress. Its rapid calcium response supports calcium signaling pathway studies, while its concentration- and time-dependent cytotoxicity supports apoptosis assay development with strict research-use-only boundaries.
-
Thapsigargin as a Probe of Stress-Network Logic
2026-09-02
Thapsigargin is a potent SERCA pump inhibitor for dissecting how calcium imbalance intersects with lysosomal, metabolic, and oxidative stress. This article translates a 2024 AMPK–SQSTM1 study into a practical assay strategy that separates direct calcium effects from downstream stress-network adaptation.
-
Shenqi Fuzheng Injection in Glioma: SRC/PI3K/AKT
2026-09-01
A 2024 Journal of Ethnopharmacology study combined network pharmacology with cellular and mouse experiments to investigate how Shenqi Fuzheng injection affects glioma progression. The results associate inhibition of proliferation, S-phase progression, migration, and transplanted tumor growth with modulation of the SRC/PI3K/AKT signaling axis, while also highlighting important limits on causal and clinical interpretation.
-
UTP Solution for RNA and Olfactory Receptor Studies
2026-09-01
A high-purity UTP Solution supports reproducible in vitro transcription, RNA amplification, siRNA synthesis, and nucleotide-dependent metabolic assays. This workflow-focused guide shows how to connect dependable RNA production with the TRIM66 olfactory-receptor findings while keeping reagent use, controls, and limitations explicit.
-
Thapsigargin: SERCA Pump Inhibitor Guide
2026-08-31
Thapsigargin is a potent SERCA pump inhibitor used to trigger controlled intracellular calcium elevation, endoplasmic reticulum stress, and cell-death responses. Its nanomolar activity makes it useful for calcium signaling pathway studies, apoptosis assays, and mechanistic stress-response experiments, but it is intended for research use only.
-
Salinomycin: A Better HCC Assay Framework
2026-08-31
Salinomycin research is more informative when growth inhibition is separated from actual cancer-cell killing. This article presents a mechanism-aware hepatocellular carcinoma assay framework that integrates Wnt/β-catenin signaling, transporter biology, calcium stress, and orthogonal apoptosis measurements.
-
BMS-345541 Hydrochloride and Cell Fate
2026-08-30
A translational framework for using BMS-345541 hydrochloride as a selective IKK inhibitor while distinguishing NF-κB suppression from RIPK1-regulated apoptosis and necroptosis. The article connects inflammation research, T-cell acute lymphoblastic leukemia, assay design, formulation strategy, and biomarker planning without overstating preclinical evidence.
-
EZ Cap™ Cre mRNA (m1Ψ) Workflows
2026-08-29
Use EZ Cap™ Cre mRNA (m1Ψ) as a transient Cre recombinase mRNA payload for reporter activation, delivery benchmarking, and controlled gene-editing studies. Its m1Ψ modification, Cap 1 structure, and poly(A) tail support a practical workflow for separating payload expression from carrier and tissue-targeting performance.